Graf Akcie DRNA (Dicerna Pharmaceuticals Inc). Diskuze k akciím DRNA. Aktuální informace DRNA.

Základní informace o společnosti Dicerna Pharmaceuticals Inc (Akcie DRNA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	1.65B
Hodnota podniku (EV)	N/A
Tržby	178.771M
EBITDA	N/A
Zisk	-129.22
Růst v tržbách Q/Q	2.20 %
Růst v tržbách Y/Y	99.54 %
P/E (Cena vůči ziskům)	0.00
Forward P/E	-0.52
EV/Sales	6.04
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	8.98
P/FCF	143.13
Price/Book	11.65
Účetní hodnota na akcii	1.82
Hotovost na akcii	7.53
FCF vůči ceně	0.70 %
Počet zaměstnanců	302
Tržba na zaměstnance	591.957k
Profit margin	-68.62 %
Operating margin	-69.31 %
Gross margin	100.00 %
EBIT margin	-71.96 %
EBITDA margin	-97.32 %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	23.26 %
EPS - Očekávaný růst příští rok	58.62 %
Return on assets	-17.75 %
Return on equity	-97.72 %
ROIC	-17.27 %
ROCE	-20.39 %
Dluhy/Equity	4.14
Čistý dluh/EBITDA	17.67
Current ratio	2.97
Quick Ratio	2.97
Volatilita	4.07
Beta	0.90
RSI	52.19
Cílová cena analytiků	35
Známka akcie (dle analytiků)	1.09
Insider ownership	7.24 %
Institutional ownership	84.67 %
Počet akcií	77.734M
Procento shortovaných akcií	6.90 %
Short ratio	7.04 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2014
Země	United States

Finanční výsledky akcie DRNA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$23.904	$6.176	$1.03	-	$0.184	-
Cost Of Goods Sold	-	-	-	-	-	-
Gross Profit	$23.904	$6.176	$1.03	-	$0.184	-
Research And Development Expenses	$109.339	$45.711	$35.888	$41.399	$43.971	$29.453
SG&A Expenses	$42.751	$21.685	$16.838	$15.433	$19.24	$15.648
Other Operating Income Or Expenses	-	$-29.132	$-9.043	$-2.916	-	-
Operating Expenses	$152.09	$96.528	$61.769	$59.748	$63.211	$45.101
Operating Income	$-128.186	$-90.352	$-60.739	$-59.748	$-63.027	$-45.101
Total Non-Operating Income/Expense	$7.727	$1.499	$0.539	$0.235	$0.188	$-2.838
Pre-Tax Income	$-120.459	$-88.853	$-60.2	$-59.513	$-62.839	$-47.939
Income Taxes	-	-	-	-	-	-
Income After Taxes	$-120.459	$-88.853	$-60.2	$-59.513	$-62.839	$-47.939
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-120.459	$-88.853	$-60.2	$-59.513	$-62.839	$-47.939
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-120.459	$-88.853	$-80.292	$-59.513	$-62.839	$-48.143
EBITDA	$-130.491	$-90.704	$-60.13	$-58.835	$-62.166	$-44.253
EBIT	$-128.186	$-90.352	$-60.739	$-59.748	$-63.027	$-45.101
Basic Shares Outstanding	68	56	22	21	20	16
Shares Outstanding	68	56	22	21	20	16
Basic EPS	$-1.76	$-1.60	$-3.66	$-2.87	$-3.09	$-3.00
EPS - Earnings Per Share	$-1.76	$-1.60	$-3.66	$-2.87	$-3.09	$-3.00

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$348.881	$302.626	$113.678	$45.874	$94.609	$96.122
Receivables	$200.354	$100	$1.583	-	-	-
Inventory	-	-	-	-	-	-
Pre-Paid Expenses	$6.934	$2.888	$3.415	$1.952	$1.532	$1.194
Other Current Assets	-	-	-	-	-	-
Total Current Assets	$556.169	$405.514	$118.676	$47.826	$96.141	$97.316
Property, Plant, And Equipment	$7.076	$2.718	$1.512	$2.234	$2.684	$2.165
Long-Term Investments	-	-	-	-	-	$2.501
Goodwill And Intangible Assets	-	-	-	-	-	-
Other Long-Term Assets	$4.062	$0.809	$0.814	$1.192	$1.198	$1.623
Total Long-Term Assets	$41.24	$3.527	$2.326	$3.426	$3.882	$6.289
Total Assets	$597.409	$409.041	$121.002	$51.252	$100.023	$103.605
Total Current Liabilities	$241.735	$94.055	$16.826	$10.044	$9.001	$5.159
Long Term Debt	-	-	-	-	-	-
Other Non-Current Liabilities	$0.608	-	-	-	-	$0.106
Total Long Term Liabilities	$203.479	$114.293	$3.09	-	-	$0.106
Total Liabilities	$445.214	$208.348	$19.916	$10.044	$9.001	$5.265
Common Stock Net	$0.007	$0.007	$0.005	$0.002	$0.002	$0.003
Retained Earnings (Accumulated Deficit)	$-525.316	$-404.809	$-315.956	$-255.756	$-196.243	$-133.404
Comprehensive Income	-	-	-	-	-	-
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$152.195	$200.693	$101.086	$41.208	$91.022	$98.34
Total Liabilities And Share Holders Equity	$597.409	$409.041	$121.002	$51.252	$100.023	$103.605

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-120.459	$-88.853	$-60.2	$-59.513	$-62.839	$-47.939
Total Depreciation And Amortization - Cash Flow	$-2.305	$-0.352	$0.609	$0.913	$0.861	$0.848
Other Non-Cash Items	$21.378	$18.215	$7.821	$9.165	$9.732	$10.939
Total Non-Cash Items	$19.073	$17.863	$8.43	$10.078	$10.593	$11.787
Change In Accounts Receivable	-	-	-	-	-	-
Change In Inventories	-	-	-	-	-	-
Change In Accounts Payable	$2.067	$-1.217	$0.626	$1.644	$1.384	$-0.097
Change In Assets/Liabilities	$89.14	$86.531	$6.228	$-0.414	$-0.177	$-1.171
Total Change In Assets/Liabilities	$100.694	$89.288	$6.443	$0.688	$3.447	$1.388
Cash Flow From Operating Activities	$-0.692	$18.298	$-45.327	$-48.747	$-48.799	$-34.764
Net Change In Property, Plant, And Equipment	$-6.349	$-0.359	$-0.133	$-0.449	$-1.134	$-2.013
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-	-	-
Net Change In Short-term Investments	-	-	-	-	-	-
Net Change In Long-Term Investments	$55.88	$-202.372	$-19.719	$13.469	$33.871	$-72.632
Net Change In Investments - Total	$55.88	$-202.372	$-19.719	$13.469	$33.871	$-72.632
Investing Activities - Other	-	-	-	-	$0.264	$-1.116
Cash Flow From Investing Activities	$49.531	$-202.731	$-19.852	$13.02	$33.001	$-75.761
Net Long-Term Debt	-	-	-	-	-	$-5.026
Net Current Debt	-	-	-	-	-	-
Debt Issuance/Retirement Net - Total	-	-	-	-	-	$-5.026
Net Common Equity Issued/Repurchased	$52.938	$170.621	$43.515	$0.561	$45.865	$95.023
Net Total Equity Issued/Repurchased	$52.938	$170.621	$112.765	$0.561	$45.865	$95.023
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	$-0.05	$-0.738	$-0.034	$-0.027	$-0.076	-
Cash Flow From Financial Activities	$52.888	$169.883	$112.731	$0.534	$45.789	$89.997
Net Cash Flow	$101.727	$-14.55	$47.552	$-35.193	$29.991	$-20.528
Stock-Based Compensation	$18.822	$7.888	$7.77	$9.165	$9.732	$8.237
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	2.3007	4.3115	7.0531	4.7616	10.6812	18.8634
Long-term Debt / Capital	-	-	-	-	-	-
Debt/Equity Ratio	-	-	-	-	-	-
Gross Margin	100	100	100	-	100	-
Operating Margin	-536.2534	-1462.953	-5896.99	-	-34253.8	-
EBIT Margin	-536.2534	-1462.953	-5896.99	-	-34253.8	-
EBITDA Margin	-545.8961	-1468.653	-5837.864	-	-33785.87	-
Pre-Tax Profit Margin	-503.9282	-1438.682	-5844.661	-	-34151.63	-
Net Profit Margin	-503.9282	-1438.682	-7795.34	-	-34151.63	-
Asset Turnover	0.04	0.0151	0.0085	-	0.0018	-
Inventory Turnover Ratio	-	-	-	-	-	-
Receiveable Turnover	0.1193	0.0618	0.6507	-	-	-
Days Sales In Receivables	3059.288	5909.974	560.966	-	-	-
ROE - Return On Equity	-79.1478	-44.2731	-59.5533	-144.4209	-69.0372	-48.7482
Return On Tangible Equity	-79.1478	-44.2731	-59.5533	-144.421	-69.0372	-48.7482
ROA - Return On Assets	-20.1636	-21.7223	-49.7513	-116.1184	-62.8246	-46.2709
ROI - Return On Investment	-79.1478	-44.2731	-59.5533	-144.421	-69.0372	-48.7482
Book Value Per Share	2.1264	2.9422	1.9573	2.0009	4.4196	5.5288
Operating Cash Flow Per Share	-0.3391	2.3971	0.2846	0.0487	-0.2381	369.2856
Free Cash Flow Per Share	-0.4255	2.3968	0.3001	0.0829	-0.1686	383.1779

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/DRNA', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie DRNA (Dicerna Pharmaceuticals Inc). Diskuze k akciím DRNA. Aktuální informace DRNA.

Základní informace o společnosti Dicerna Pharmaceuticals Inc (Akcie DRNA)

Finanční výsledky akcie DRNA